secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001104659-24-010063
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elutia reprices stock options and grants new equity to CEO, CFO, CSO, and other employees
--------------------------------------------------------------------------------

- CEO C. Randal Mills' existing options and RSUs vesting thresholds lowered to $6, $10, $14, $18 per share.
- CEO granted 650,000 options and 650,000 RSUs; CFO and CSO each granted 200,000 options and 200,000 RSUs.
- Non-executive employee options repriced from >$7 to $3.61 per share, covering 144,427 shares.
- New equity grants to other employees include 565,561 options and 1,167,500 RSUs.
- Vesting of some awards contingent on FDA clearance of CanGarooRM antibiotic-eluting envelope.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465924010063/0001104659-24-010063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465924010063/tm244998d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-010063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer